Evidence map›Paper›PMID 31929818›Full record

ArticleEvidence-based complementary and alternative medicine : eCAM2019

Optimization of Cinnamon (

Imen Kallel, Bilel Hadrich, Bochra Gargouri, Amina Chaabane, Saloua Lassoued, Radhouane Gdoura, Ahmed Bayoudh, Ezeddine Ben Messaoud

Open access · hybridAbstract read
In one paragraph

Article in Evidence-based complementary and alternative medicine : eCAM, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
6.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 75 citations in OpenAlex.

  1. Article
  2. Extraction of bioactive compounds fromJournal of food science and technology · 2025
    Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Spicing Up Meat Preservation:Foods (Basel, Switzerland) · 2024
    Review
  8. Article
  9. Review
  10. Cinnamon: a nutraceutical supplement for the cardiovascular system.Archives of medical sciences. Atherosclerotic diseases · 2024
    Article
  11. Review
  12. Review
  13. Chemical Composition of theAntibiotics (Basel, Switzerland) · 2023
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Imen KallelLaboratoire de Recherche Toxicologie Microbiologie Environnementale et Santé (LR17ES06), Faculté des Sciences de Sfax, P.O. Box 1171, 3000 Sfax, Université de Sfax, Tunisia.
Bilel HadrichUnité de Biotechnologie des Algues, Biological Engineering Department, National School of Engineers of Sfax, University of Sfax, Sfax 3038, Tunisia.ORCID https://orcid.org/0000-0002-0671-4018
Bochra GargouriUnité de Recherche Biotechnologie et Pathologies, Institut Supérieur de Biotechnologie de Sfax, University of Sfax, Sfax, Tunisia.
Amina ChaabaneLaboratoire de Recherche Toxicologie Microbiologie Environnementale et Santé (LR17ES06), Faculté des Sciences de Sfax, P.O. Box 1171, 3000 Sfax, Université de Sfax, Tunisia.
Saloua LassouedUnité de Recherche Biotechnologie et Pathologies, Institut Supérieur de Biotechnologie de Sfax, University of Sfax, Sfax, Tunisia.
Radhouane GdouraLaboratoire de Recherche Toxicologie Microbiologie Environnementale et Santé (LR17ES06), Faculté des Sciences de Sfax, P.O. Box 1171, 3000 Sfax, Université de Sfax, Tunisia.
Ahmed BayoudhLaboratory of Enzyme Engineering and Microbiology, Engineering National School of Sfax (ENIS), University of Sfax, Sfax, Tunisia.
Ezeddine Ben MessaoudLaboratoire de Recherche Toxicologie Microbiologie Environnementale et Santé (LR17ES06), Faculté des Sciences de Sfax, P.O. Box 1171, 3000 Sfax, Université de Sfax, Tunisia.ORCID https://orcid.org/0000-0003-0667-2417
University of Sfax · TN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Having high cytotoxicity cell line effect,

Identifiers

PMID31929818
PMCPMC6942840
OpenAlexW2997064429

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.